Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Mounjaro Lawsuits: Popular Drug Used for Weight Loss Causes Stomach Paralysis

Mounjaro is an injectable drug approved by the FDA to treat type 2 diabetes. Although approved for managing diabetes, studies indicate that Mounjaro’s active ingredient, tirzepatide, may be more effective than Wegovy or Ozempic for weight loss. This has led to a rise in patients using Mounjaro off-label for weight management. While the drug can aid in dramatic weight loss, high doses can also cause severe injuries like gastroparesis (stomach paralysis).

If you took Mounjaro and were later diagnosed with gastroparesis, call the Michael Brady Lynch Firm at 888-585-5970. You may be eligible for compensation for your injuries.

What’s the Mounjaro Lawsuit About?

Mounjaro is manufactured by Eli Lilly and was approved in 2022 to treat type 2 diabetes. Although the FDA hasn’t approved the drug for weight loss, one study by the New England Journal of Medicine found that patients prescribed Mounjaro lost more weight than patients who took semaglutide drugs like Wegovy and Ozempic. This led many physicians across the country to prescribe Mounjaro for weight management. With the increased number of patients using Mounjaro, the number of cases of adverse side effects due to taking Mounjaro also increased. Patients have reported severe gastrointestinal problems such as gastroparesis after taking high doses of Mounjaro. Mounjaro lawsuits claim Mounjaro’s manufacturer, Eli Lilly, failed to warn patients about the risks of gastroparesis while taking the drug.

Are There Long-Term Side Effects of Mounjaro?

While Moujaro is a relatively new drug and long-term studies haven’t been concluded, there have been reports of serious health issues like gallbladder disease, gallstones, and gastroparesis after taking at least two doses of Mounjaro. Other side effects include nausea, vomiting, pancreatitis, and hypoglycemia.

Eli Lilly Failed To Warn Patients

Mounjaro lawsuits claim that Eli Lilly knew about the risks of gastroparesis and other gastrointestinal issues but failed to warn patients and prescribers. The FDA issued a box warning on Mounjaro, the highest level of warning the FDA can issue, related to the risk of gallbladder disease while using the drug. However, Mounjaro’s label doesn’t include warnings about gastroparesis.

Eli Lilly responded with an open letter discouraging patients from using Moujaro for weight loss, indicating that the effects of Mounjaro haven’t been studied on patients with severe gastrointestinal issues and that the drug has only been approved for type 2 diabetes management.

Mounjaro Latest Cases

Mounjaro lawsuits have been consolidated into a multidistrict litigation with other GLP-1 receptor drugs like Wegovy and Ozempic. As of December 2024, there are 1,300 pending GLP-1 cases filed from patients who used Mounjaro, Wegovy, or Ozempic and were later diagnosed with gastroparesis. These cases claim that GLP-1 receptor drug manufacturers knew the risks of developing gastroparesis and failed to warn patients and prescribers.

Key Injuries and Mounjaro Lawsuit Eligibility

Our law firm is currently accepting GLP-1 drug cases from those who used Mounjaro, Wegovy, and Ozempic. The key injury criteria are:

  • Gastroparesis
  • Gallbladder disorders
  • Ischemic Optic Neuropathy (eye stroke)
  • Pancreatitis
  • Diabetic Retinopathy
  • Intestinal blockage or obstruction

You may be eligible for compensation if you used Mounjaro, Ozempic, or Wegovy and were later diagnosed with one of these conditions. Call our office at 888-585-5970 to discuss your case.

For information about the GLP-1 receptor MDL, view our resources:

Mass Tort Abuses in the Mormon Church: A Legal Perspective

Mass Tort Abuses in the Mormon Church: A Legal Perspective

In recent years, the Church of Jesus Christ of Latter-day Saints (LDS), commonly known as the Mormon Church, has faced increasing legal scrutiny due to allegations of widespread abuse and institutional cover-ups. have come forward with claims of sexual, emotional, and physical abuse, many of which involve church leaders or institutions. These lawsuits have begun to take the form of mass tort claims, as multiple plaintiffs allege a systemic pattern of negligence and concealment within the organization.

read more
Understanding Copyright Law for OnlyFans Creators

Understanding Copyright Law for OnlyFans Creators

OnlyFans has become a booming platform for influencers and content creators, allowing them to monetize their work directly through subscriptions. However, with the rise of digital content creation comes the inevitable challenge of copyright infringement. Many OnlyFans creators find their exclusive content stolen and redistributed on unaffiliated websites without their permission. If you’re an OnlyFans influencer facing this issue, you may have legal recourse to protect your rights.

read more
Update on The New Maryland Child Sexual Abuse Law

Update on The New Maryland Child Sexual Abuse Law

Maryland recently made a landmark change to its legal landscape by eliminating the civil statute of limitations for child sexual abuse cases under the **Child Victims Act of 2023**. This law, upheld by the Maryland Supreme Court in February 2025, allows survivors to file lawsuits regardless of how much time has passed since the abuse occurred.

read more
PIP Insurance Coverage Florida: How it Works

PIP Insurance Coverage Florida: How it Works

Florida is one of 12 “no-fault” insurance states, requiring drivers to carry Personal Injury Protection (PIP) insurance on vehicles operated in the state. PIP insurance allows injured drivers to receive compensation for damages and medical expenses by utilizing their insurance coverage.

read more
An Update on PFAS Cases: New Contamination Sites in US

An Update on PFAS Cases: New Contamination Sites in US

Per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” have been a growing concern due to their persistence in the environment and potential health risks. Recent developments have highlighted new contamination sites and legal actions aimed at addressing these issues across the United States.

read more
Nursing Home Abuse: An Overview

Nursing Home Abuse: An Overview

Nursing home abuse involves the mistreatment, neglect, or exploitation of residents in long-term care facilities. This includes skilled nursing homes, assisted living facilities, and other institutions responsible for the care of elderly or vulnerable adults. Under both federal and state laws, these facilities are required to provide residents with a safe, dignified, and compassionate environment.

read more
Oxbryta Recall: What You Need to Know

Oxbryta Recall: What You Need to Know

Oxbryta is a prescription medication developed to help people with sickle cell disease (SCD). It works by improving the oxygen-carrying ability of red blood cells and reducing the complications that come with SCD, like pain crises and organ damage. While it’s been seen as a breakthrough for managing this condition, a recent recall has raised serious concerns about its safety.

read more
Wegovy Lawsuits and Media Attention Increase

Wegovy Lawsuits and Media Attention Increase

Wegovy is a concentrated form of semaglutide, a GLP-1 receptor drug approved by the FDA to manage type 2 diabetes and weight loss. Wegovy is similar to Ozempic and manufactured by the same drug company, Novo Nordisk. As we’ve reported recently, patients who suffered from gastroparesis and blindness after taking Ozempic are filing cases against the drug’s manufacturer.

read more
×
What Our Clients Are Saying